Cargando…

Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis

BACKGROUND: The use of mucins (MUC) as specific biomarkers for various malignancies has recently emerged. MUC1, MUC4, MUC5AC, and MUC16 can be detected at different stages of pancreatic cancer (PC), and can be valuable for indicating the initiation and progression of this disease. However, the diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shunda, You, Lei, Dai, Menghua, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940915/
https://www.ncbi.nlm.nih.gov/pubmed/33708819
http://dx.doi.org/10.21037/atm-20-5606
_version_ 1783662045611163648
author Wang, Shunda
You, Lei
Dai, Menghua
Zhao, Yupei
author_facet Wang, Shunda
You, Lei
Dai, Menghua
Zhao, Yupei
author_sort Wang, Shunda
collection PubMed
description BACKGROUND: The use of mucins (MUC) as specific biomarkers for various malignancies has recently emerged. MUC1, MUC4, MUC5AC, and MUC16 can be detected at different stages of pancreatic cancer (PC), and can be valuable for indicating the initiation and progression of this disease. However, the diagnostic significance of the mucin family in patients with PC remains disputed. Herein, we assessed the diagnostic accuracy of mucins in PC using a meta-analysis. METHODS: We searched the PubMed, Cochrane Library, Institute for Scientific Information (ISI) Web of Science, Embase, and Chinese databases from their date of inception to June 1, 2020 to identify studies assessing the diagnostic performance of mucins in PC. The estimations of diagnostic indicators in selected studies were extracted for further analysis by Meta-DiSc software. Publication bias was assessed using Deeks’ funnel plot asymmetry test. RESULTS: Our meta-analysis included 34 studies. The pooled accuracy indicators of MUC1 in PC including the sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) (with 95% confidence intervals) were 0.84 (0.82–0.86), 0.60 (0.56–0.64), 18.37 (9.18–36.78), 2.62 (1.79–3.86), and 0.22 (0.15–0.33), respectively. The area under the summary receiver operating characteristic (SROC) curve was 0.8875 and the Q index was 0.8181. Quantitative random-effects meta-analysis of MUC4 in PC using the summary (ROC) curve model revealed a pooled sensitivity of 0.86 (95% confidence interval, 0.82–0.89) and specificity of 0.88 (95% confidence interval, 0.85–0.91). In addition, the meta-analysis of MUC5AC in PC diagnosis also showed a high sensitivity and specificity of 0.71 (95% confidence interval, 0.65–0.76) and 0.60 (95% confidence interval, 0.53–0.66), respectively. Regarding MUC16, the area under the summary ROC curve and Q index were 0.9185 and 0.8516, respectively. CONCLUSIONS: In summary, our results suggested a good diagnostic accuracy of several crucial mucins in PC. Mucins may serve as optional indicators in PC examination, and further research is warranted to investigate the role of mucins as potential clinical biomarkers.
format Online
Article
Text
id pubmed-7940915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-79409152021-03-10 Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis Wang, Shunda You, Lei Dai, Menghua Zhao, Yupei Ann Transl Med Original Article BACKGROUND: The use of mucins (MUC) as specific biomarkers for various malignancies has recently emerged. MUC1, MUC4, MUC5AC, and MUC16 can be detected at different stages of pancreatic cancer (PC), and can be valuable for indicating the initiation and progression of this disease. However, the diagnostic significance of the mucin family in patients with PC remains disputed. Herein, we assessed the diagnostic accuracy of mucins in PC using a meta-analysis. METHODS: We searched the PubMed, Cochrane Library, Institute for Scientific Information (ISI) Web of Science, Embase, and Chinese databases from their date of inception to June 1, 2020 to identify studies assessing the diagnostic performance of mucins in PC. The estimations of diagnostic indicators in selected studies were extracted for further analysis by Meta-DiSc software. Publication bias was assessed using Deeks’ funnel plot asymmetry test. RESULTS: Our meta-analysis included 34 studies. The pooled accuracy indicators of MUC1 in PC including the sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) (with 95% confidence intervals) were 0.84 (0.82–0.86), 0.60 (0.56–0.64), 18.37 (9.18–36.78), 2.62 (1.79–3.86), and 0.22 (0.15–0.33), respectively. The area under the summary receiver operating characteristic (SROC) curve was 0.8875 and the Q index was 0.8181. Quantitative random-effects meta-analysis of MUC4 in PC using the summary (ROC) curve model revealed a pooled sensitivity of 0.86 (95% confidence interval, 0.82–0.89) and specificity of 0.88 (95% confidence interval, 0.85–0.91). In addition, the meta-analysis of MUC5AC in PC diagnosis also showed a high sensitivity and specificity of 0.71 (95% confidence interval, 0.65–0.76) and 0.60 (95% confidence interval, 0.53–0.66), respectively. Regarding MUC16, the area under the summary ROC curve and Q index were 0.9185 and 0.8516, respectively. CONCLUSIONS: In summary, our results suggested a good diagnostic accuracy of several crucial mucins in PC. Mucins may serve as optional indicators in PC examination, and further research is warranted to investigate the role of mucins as potential clinical biomarkers. AME Publishing Company 2021-02 /pmc/articles/PMC7940915/ /pubmed/33708819 http://dx.doi.org/10.21037/atm-20-5606 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Wang, Shunda
You, Lei
Dai, Menghua
Zhao, Yupei
Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title_full Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title_fullStr Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title_full_unstemmed Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title_short Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
title_sort quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940915/
https://www.ncbi.nlm.nih.gov/pubmed/33708819
http://dx.doi.org/10.21037/atm-20-5606
work_keys_str_mv AT wangshunda quantitativeassessmentofthediagnosticroleofmucinfamilymembersinpancreaticcancerametaanalysis
AT youlei quantitativeassessmentofthediagnosticroleofmucinfamilymembersinpancreaticcancerametaanalysis
AT daimenghua quantitativeassessmentofthediagnosticroleofmucinfamilymembersinpancreaticcancerametaanalysis
AT zhaoyupei quantitativeassessmentofthediagnosticroleofmucinfamilymembersinpancreaticcancerametaanalysis